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THE PHYSIOLOGICAL EFFECTS of leptin on energy balance and sympathetic nervous system activity are mediated by activation of the long form of the leptin receptor (LR) in the central nervous system (CNS) (14, 17, 18) . Although the precise CNS mechanisms by which leptin chronically regulates cardiovascular and metabolic function are only beginning to be elucidated, previous studies suggest that the CNS melanocortin system may play a crucial role in mediating the effects of leptin on blood pressure (BP) and glucose regulation. Activation of LR in proopiomelanocortin (POMC) neurons leads to depolarization of these neurons and release of ␣-melanocyte-stimulated hormone (␣-MSH), the endogenous agonist of melanocortin 4 receptors (MC4R) (6) .
Previously, we have demonstrated that deletion of LR in POMC neurons does not recapitulate the severe obesity and hyperphagia observed in leptin-deficient or MC4R-deficient mice but abolishes the chronic effects of leptin to raise BP and to improve glucose homeostasis (8) . However, the signaling pathways by which LR activation in POMC neurons differentially regulate cardiovascular and metabolic function are still unclear.
Stimulation of the LR in neurons results in phosphorylation and activation of JAK, which activates three signaling pathways: STAT3, Src homology-2 tyrosine phosphatase (Shp2), and insulin receptor substrate 2 (Irs2) (14, 18) . We previously found that deletion of STAT3 signaling in POMC neurons attenuated the BP but not the appetite-suppressant or thermogenic effects of leptin (10) . However, the role of the other POMC LR signaling pathways in mediating differential control of cardiovascular and metabolic function by leptin have not been previously reported.
Shp2 signaling in the CNS has been shown to contribute to regulation of body weight. Zhang et al. (19) found that mice with Shp2 deficiency in forebrain neurons are obese and have several characteristics of the metabolic syndrome, including hyperglycemia, hyperinsulinemia, and insulin resistance, indicating that Shp2 may play an important role in regulating energy balance and metabolism. In addition, deletion of Shp2 in POMC neurons impaired glucose tolerance and reduced POMC mRNA and ␣-MSH (2, 5) . Although these observations suggest that LR signaling through Shp2 is important for regulating body weight and glucose, the role of POMC neuronal Shp2 signaling in mediating the chronic BP effects of leptin is still unknown. Moreover, there have been no previous studies, to our knowledge that have determined the role of Shp2 signaling in POMC neurons in mediating the chronic actions of leptin on appetite, thermogenesis, and glucose homeostasis.
In the current study, we used a genetic approach to produce Shp2 deficiency, specifically in POMC neurons to test the hypothesis that Shp2 in POMC neurons is essential for the chronic effects of leptin on metabolic and cardiovascular functions. Our results indicate that Shp2 signaling in POMC neurons plays a key role in mediating the BP and antidiabetic actions of leptin but only a modest role in normal regulation of appetite and body weight.
METHODS
The experimental procedures and protocols for these studies followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center.
Animals
Male 22-wk-old Shp2/Pomc-cre (n ϭ 21) and Shp2 flox/flox control mice (n ϭ 24) were used in these studies. Shp2 flox/flox /Pomc-cre mice were generated by crossing Pomc-cre mice (C57BL/6J background), which express cre-recombinase under the control of POMC promoter, as previously described (1), with Shp2 flox/flox (129-C57BL/6J 2) mice (9, 19) . Homozygous mice for the Shp2 flox/flox gene that also expressed cre-recombinase were used as Shp2/Pomc-cre mice. Littermate homozygous Shp2 flox/flox mice from our colony were used as controls for the chronic experiments (Fig. 1A) .
Body Weight and Body Composition Analysis
A group of male Shp2/Pomc-cre (n ϭ 12) and Shp2 flox/flox (n ϭ 8) mice were individually housed and fed standard chow (Harlan Teklad, Madison, WI) for weekly determination of body weight and body composition starting at 6 wk of age through 22 wk of age to examine the role of Shp2 in POMC neurons in regulating body weight. Body composition was performed using magnetic resonance imaging (EchoMRI-900TM; Echo Medical System, Houston, TX) to quantify lean mass, fat mass, and free water, and total water content in conscious mice.
Telemetry Probe and Venous Catheter Implantation
Under isoflurane anesthesia, male Shp2/Pomc-cre (n ϭ 7), Shp2 flox/ flox (n ϭ 9) mice were implanted with telemetric pressure transmitter probes in the left carotid artery for determination of mean arterial pressure (MAP) and heart rate (HR), 24-h per day, using computerized methods for data collection, as previously described (8, 9) . Daily MAP and HR were obtained from the 24-h recordings using a sampling rate of 1,000 Hz with duration of 10 s every 10-min period. A venous catheter was also implanted in the jugular vein for infusions of saline vehicle or leptin. The venous catheter was tunneled subcutaneously, exteriorized between the scapulas, and passed through a spring connected to a mouse swivel (Instech) mounted on the top of the metabolic cage. The venous catheter was connected through a sterile filter to a syringe pump for continuous saline and leptin infusions. Food and water were offered ad libitum throughout the experiment, and room temperature was maintained at 23-24°C. A normal sodium intake of ϳ460 mol/day was maintained via the constant saline infusion combined with sodium-deficient rodent chow, as previously described (8, 16) . The mice were allowed to recover for 8 -10 days after surgery before baseline measurements were taken.
Glucose Tolerance Test
D-glucose (3 mg/kg of lean tissue plus 1 mg/kg of fat mass) was administered by gavage after a 6-h fast in 22-wk-old male Shp2/ Pomc-cre (n ϭ 7) and Shp2 flox/flox mice (n ϭ 9). Blood samples were collected by tail snip, and blood glucose was measured at 0, 15, 30, 60, 90, and 120 min after glucose injection using glucose strips (Reli On).
Experimental Design
Acute and chronic leptin infusion. To determine the role of Shp2 in POMC neurons in mediating the acute effects of leptin on appetite, food intake was measured 2, 4, 16, and 24 h after intraperitoneal leptin (5 mg/kg) or saline vehicle injections (0.3 ml) between 5:00 and 6:00 PM in a separate group of noninstrumented and nonfasted Shp2 flox/flox (n ϭ 5) and Shp2/Pomc-cre mice (n ϭ 5) at 22 wk of age.
After an 8 -10-day postsurgery recovery period and 5 days of stable baseline control measurements, leptin was added to the saline vehicle and infused at the rate of 2 g·kg Ϫ1 ·min Ϫ1 in additional groups of instrumented Shp2 flox/flox (n ϭ 9) and Shp2/Pomc-cre mice (n ϭ 7) for 7 days followed by a 5-day posttreatment period during which only saline vehicle was infused intravenously. MAP, HR, urine volume, and food and water intake were recorded daily. Blood samples (100 l) were collected via a tail snip after 6 h of fasting (8:00 AM to 2:00 PM) during the control period (day 5), on the last day of leptin infusion (day 7 of treatment), and at the end of the posttreatment period for measurements of plasma glucose, leptin, and insulin concentrations.
Acute air-jet stress test. To determine whether leptin receptor deficiency in POMC neurons alters the MAP and HR responses to an acute pressor stress, Shp2 flox/flox /Pomc-cre (n ϭ 6) and Shp2 flox/flox (n ϭ 5) mice were placed in a special cage used for air-jet stress testing. Briefly, after a 2-h period for acclimatization to the cage, MAP and HR were continuously measured, using telemetry, for 30 min before the air-jet stress test was applied. The air-jet stress test consisted of 2-s pulses of air-jet delivery every 5 s during 5 consecutive minutes aimed at the forehead of the mice at a distance of ϳ5 cm using a 14-gauge needle opening at the front of the tube connected to compressed air. After the 5-min air-jet stress, MAP and HR were measured for an additional 30-min recovery period. BP and HR responses during the air-jet stress and recovery period following the air-jet stress were calculated as the changes compared with baseline period (average of the last 10 min of baseline measurements before air-jet stress was initiated). We also calculated the areas under the MAP and HR curve (AUC) during the air-jet stress and recovery periods using the following parameters: average change in MAP for each minute during the 5-min air-jet stress test and for each 5 min during the 30-min recovery period. Oxygen consumption and motor activity. In separate experiments, Shp2 flox/flox (n ϭ 9) and Shp2/Pomc-cre mice (n ϭ 7) at 22 wk of age were placed individually in metabolic cages (AccuScan Instruments, Columbus, OH) equipped with oxygen sensors to measure oxygen consumption (V O2) and infrared beams to determine motor activity. V O2 was measured for 2 min at 10-min intervals continuously 24 h a day using a Zirconia oxygen sensor. Motor activity in x, y, and z axes was determined using infrared light beams mounted in the cages. After the mice were acclimatized to the new environment for ϳ4 -6 days, V O2 and animal activity were recorded for three consecutive days. Then the mice were lightly anesthetized with isoflurane, and an osmotic minipump (model 1007D, Durect) was placed intraperitoneally to deliver leptin (4 g·kg Ϫ1 ·min Ϫ1 ) for 7 days. Mice were followed for an additional 5-day posttreatment period.
Analytical Methods
Polymerase chain reaction. Genotyping was performed as previously described (2, 9) . Briefly, after weaning at 4 wk of age, mice were genotyped using tail snips to perform PCR across the Shp2 flox/flox exon 6 and for cre-recombinase using the following primers: 5=-GGAAGATGAACTCCACCCACC-3=, 5=-ACGATGGTTTCCGAC-CCATTC-3=, GAGCCCAGAAAGCGAAGGAAC-3=; and for cre positive 5=-CTGCCACGACCA AGTGACAGC-3=, and cre negative 5=-CTTCTCTACACCTGCGGTGCT-3=. To detect the Shp2 flox/flox allele, a forward primer 5=-ACGTCATGATCCGCTGTCAG-3= and reverse primer 5=-GCAGGAGATTGCAGCTCAGTGATG-3 were used. Only animals that tested positive for the Shp2 flox/flox and cre (homozygous) were used as Shp2/Pomc-cre mice.
Immunohistochemistry. Rosa-Pomc-cre and of Shp2-Rosa/Pomccre mice at 20 wk of age were anesthetized with isoflurane and perfused with PBS via a left ventricle puncture, and brains were collected and placed in 4% paraformaldehyde overnight and then infiltrated with 30% sucrose in PBS at 4°C. Frozen coronal sections (30 m thick) were prepared, and free-floating sections were washed in PBS and incubated for ␤-gal staining (␤-Gal Staining Set; Roche, Indianapolis, IN) overnight at 37°C. After ␤-gal staining, sections were rinsed in PBS and preincubated with 5% normal horse serum for 1 h at room temperature. After rinses with PBS, sections were incubated with mouse anti-Shp2 antibody (BD Transduction Laboratories, San Jose, CA) at a dilution of 1:100 for 48 h at 4°C. After three rinses with PBS, sections were incubated with secondary antibody (Vector Laboratories, Burlingame, CA) at a dilution of 1:400 for 30 min at room temperature. After rinses with PBS, sections were incubated with ABC reagents (Vector Laboratories) for 30 min at room temperature and then incubated with diaminobenzidine (Vector Laboratories). Sections were mounted on Superforst/Plus slides (Fisher). Colocalization of Shp2 and POMC neurons was quantified in 100 chosen LacZ-expressing POMC neurons (perinuclear blue dot) at ϫ20 magnification, and we counted the number of positive POMC neurons expressing Shp2 (brown staining) cells.
Plasma hormones and glucose measurements. Blood samples (100 l) were collected via a tail snip after 6 h of fasting (8:00 AM to 2:00 PM) during the control period (day 5), on the last day of leptin infusion (day 7), and at the end of the posttreatment period for measurements of plasma glucose, leptin, and insulin concentrations. Plasma leptin and insulin concentrations were measured with an ELISA kit [R&D Systems (Minneapolis, MN) and Crystal Chem (Downers Grove, IL), respectively], and plasma glucose concentrations were determined using the glucose oxidation method (Beckman glucose analyzer 2).
Statistical Analysis
The results are expressed as means Ϯ SE. Data were analyzed by paired t-test or one-way ANOVA with repeated measures followed by Dunnett's post hoc test for comparisons between control and experimental values within each group when appropriate. Comparisons between different groups were made by unpaired t-test or one-way ANOVA followed by Dunnett's post hoc test when appropriate. Statistical significance was accepted at a level of P Ͻ 0.05.
RESULTS
Mice were genotyped for the presence of Shp2 flox/flox transgene and cre-recombinase at 3 wk of age using DNA obtained from a tail snip. Figure 1A shows PCR amplification for Shp2 flox/flox and cre-recombinase from 15 tail snip samples with analyses, indicating the presence or absence of cre-recombinase and Shp2 flox/flox transgene. This strategy has proven successful in deleting genes of interest specifically in POMC neurons (1, 2) . To confirm deficiency of Shp2 in POMC neurons, we performed double-labeling of LacZ reporter gene and Shp2 protein in Shp2-Rosa/Pomc-cre and Rosa-Pomc-cre control mice. We observed a 79% reduction in Shp2 immunoreactivity in POMC neurons of Shp2-Rosa/Pomc-cre compared with Rosa-Pomc-cre control mice (Fig. 1B) 
Effect of Shp2 Deficiency in POMC Neurons on Body Weight, Body Composition, and Glucose Regulation
Body weight from 5 wk until 22 wk of age was measured in both groups ( Fig. 2A) . Compared with Shp2 flox/flox controls, Shp2/Pomc-cre mice were heavier (34 Ϯ 1 vs. 31 Ϯ 1 g) at 22 wk of age. Compared with controls, Shp2/Pomc-cre mice had a greater fat mass (Fig. 2, B and C) , but there were no differences in lean body mass (Fig. 2D) or body water content (data not shown). The increases in body weight occurred after 15 wk of age due mainly to increases in fat mass rather than lean mass. There were no significant differences in body length in the two groups (data not shown). These findings suggest that Shp2 deficiency in POMC neurons increases body weight after 15 wk of age but not at a young age, although fat mass was increased at an earlier age.
To further examine whether lack of Shp2 in POMC neurons impairs glucose regulation, a glucose tolerance test (GTT) was performed at 22 wk of age. Shp2/Pomc-cre mice exhibited impaired glucose tolerance as reflected by a 56% greater area under the blood glucose curve during the GTT compared with Shp2 flox/flox mice (Fig. 2, D and E) .
Effect of Shp2 Deficiency in POMC Neurons on Food Intake and Body Weight Responses to Acute and Chronic Leptin Infusion
Acute intraperitoneal leptin injection reduced 24-h food intake in both groups by ϳ30% compared with saline injection (Fig. 3A) . The acute anorexic effect of leptin was observed as early as 2 h postinjection in Shp2 flox/flox and Shp2/Pomc-cre mice. No changes in body weight were observed after acute leptin or saline injection (Shp2 flox/flox : 31 Ϯ 1 vs. 30 Ϯ 2 g and 32 Ϯ 1 vs. 33 Ϯ 2 g; Shp2/Pomc-cre: 34 Ϯ 1 vs. 32 Ϯ 2 g and 34 Ϯ 2 vs. 35 Ϯ 2 g). These data indicate that activation of Shp2 in POMC neurons is not required for the acute anorexic action of leptin. Chronic leptin infusion for 7 days also markedly reduced food intake in Shp2 flox/flox and Shp2/Pomc-cre mice (Fig. 3, B  and C) . The reduction in food intake was more pronounced in control Shp2 flox/flox mice compared with Shp2/Pomc-cre. For instance, on day 5 of leptin infusion, the reduction in food intake in Shp2/Pomc-cre mice was 30% compared with a 54% reduction in Shp2 flox/flox mice (Fig. 3B) , which led to a greater net deficit in food intake during leptin treatment (Fig. 3D ). This reduction in food intake was associated with a 10 and 8% body weight loss in Shp2 flox/flox (31 Ϯ 1 vs. 28 Ϯ 1 g) and Shp2/ Pomc-cre (34 Ϯ 2 vs. 31 Ϯ 1 g) mice, respectively. After leptin infusion was stopped, food intake and body weight returned to baseline values in both groups.
Effect of Shp2 Deficiency in POMC Neurons on Baseline BP and HR, and Responses to Stress and Chronic Leptin Infusion
Baseline MAP was ϳ6 mmHg higher in Shp2/Pomc-cre mice compared with Shp2 flox/flox mice (Fig. 4A) , while HR was similar in the two groups (Fig. 4B) . Deletion of Shp2 in POMC neurons was associated with a small, but nonsignificant, reduction in BP response to air-jet stress (Fig. 4, C  and D) , whereas the increase in HR during acute air-jet stress was attenuated by 43% compared with Shp2 flox/flox mice (Fig. 4E ). These data indicate that despite a modest elevation in baseline BP, Shp2/Pomc-cre mice exhibited normal BP responses associated with attenuated HR responses to acute air-jet stress.
We have previously shown that chronic leptin infusion in lean WT mice, to produce plasma leptin levels similar to those observed in obesity, raises BP, and that this effect requires leptin receptor activation in POMC neurons (2) . Therefore, we investigated the importance of Shp2 signaling in POMC neurons in contributing to leptin's BP actions. We found that leptin infusion in control mice gradually increased MAP by 5 mmHg, despite a marked decrease in food intake and weight loss that would tend to lower BP. In Shp2/Pomc-cre mice, however, there was no significant rise in MAP during leptin infusion (Fig. 5, A and B) . The more pronounced chronic effect of leptin infusion to increase BP in controls compared with Shp2/Pomc-cre mice is more evident when analyzing the total area under the curve (AUC) of BP during leptin infusion (Fig. 5E) , which was 84% greater in control compared with Shp2/Pomc-cre mice. Leptin caused only a transient increase in HR (during days 4 and 5 of treatment) after which HR returned to baseline values (Fig. 5, C and  D) . These data suggest that Shp2 signaling in POMC neurons may contribute to leptin's ability to increase BP.
Effect of Shp2 Deficiency in POMC Neurons on Glucose and Insulin Responses to Chronic Leptin Infusion
At baseline, no differences in fasting plasma leptin, insulin, or glucose levels were observed in Shp2 flox/flox and Shp2/Pomccre mice (Figs. 6, A-C) .
Chronic intravenous leptin infusion significantly increased plasma leptin levels in both groups, while markedly reducing plasma glucose and insulin levels in Shp2 flox/flox mice (Fig. 6, A  and B) . In contrast, leptin treatment failed to significantly reduce plasma glucose and insulin levels in Shp2/Pomc-cre mice (Fig. 6, A and B) . This suggests that Shp2 signaling in POMC neurons may play an important role in mediating the chronic effects of leptin on glucose homeostasis.
Effect of Shp2 Deficiency in POMC Neurons on V O 2 and Motor Activity Responses to Chronic Leptin Infusion
Baseline V O 2 and motor activity were similar in both groups, although there was a tendency for lower V O 2 and motor activity in Shp2/Pomc-cre mice (Fig. 6, D and E) . Chronic leptin infusion increased V O 2 by 16% in control mice and only 7% in Shp2/Pomc-cre mice (Fig. 6D) . Motor activity was significantly reduced in both groups during chronic leptin infusion (Fig. 6E) .
DISCUSSION
An important finding of this study is that Shp2 deficiency in POMC neurons attenuated the BP effects of chronic leptin treatment. Shp2 deficiency in POMC neurons was also associated with impaired glucose tolerance and attenuated leptin's ability to reduce glucose and insulin levels. Shp2 deficiency in POMC neurons had a modest effect on body weight regulation and did not attenuate the acute anorexic effects of leptin. However, POMC Shp2 deficiency did slightly attenuate the suppression of appetite and the increase in V O 2 caused by chronic infusion of high levels of leptin.
Role of Shp2 Signaling in POMC Neurons in Regulating Body Weight and Glucose Homeostasis
In a previous study, Banno et al. (2) showed that mice lacking Shp2 in POMC neurons and fed a normal chow diet had elevated body weight and adiposity, decreased anorexic response to acute leptin injection, and reduced energy expenditure despite normal food intake. These authors also observed impaired glucose tolerance and insulin sensitivity in mice fed a high-fat diet. In the present study, however, body weight in Shp2/Pomc-cre mice was not significantly different than in Shp2 flox/flox control mice until 15 wk of age when the Shp2/ Pomc-cre mice were slightly heavier. This small increase in body weight in Shp2/Pomc-cre mice was not associated with increased food intake or major alterations in oxygen consumption, but was associated with increased fat mass. However, the ability of high levels of leptin to increase energy expenditure was partially attenuated in mice with deficient Shp2 signaling in POMC neurons. Thus, our results suggest that Shp2 signaling in POMC neurons plays a modest role in normal regulation of body weight but does influence adiposity and may contribute slightly to the chronic effects of high leptin levels to suppress appetite.
Shp2 signaling in other neuronal populations, however, is also important in regulating energy balance, since we and others have shown that mice with Shp2 deficiency in the entire forebrain are obese and have many characteristics of the metabolic syndrome (9, 19) . Mice with Shp2 deletion in the forebrain also exhibit elevated plasma glucose and insulin levels (9) , suggesting that Shp2 signaling in forebrain neurons contributes importantly to regulation of peripheral glucose homeostasis. Although deletion of Shp2 in POMC neurons did not cause major changes in fasting plasma glucose and insulin levels, Shp2/Pomc-cre mice showed impaired glucose disposal during a glucose tolerance test. It seems unlikely that this effect on glucose regulation can be attributed entirely to differences in food intake since a previous study by da Silva et al. (7) showed that leptin's glucose-lowering effect cannot be explained by reductions in food intake in a model of Type 1 diabetes. They found that reducing food intake by the same amount as observed during leptin treatment caused only a small decrease in plasma glucose compared with the effects of leptin infusion. Thus, it is unlikely that the differences in plasma glucose responses to leptin infusion in Shp2/Pomc-Cre and Shp2 flox/flox control mice can be attributed to differences in food intake.
Role of Shp2 Signaling in POMC Neurons in Mediating Chronic Metabolic Effects of Leptin
We previously demonstrated that deletion of LR in POMC neurons did not significantly attenuate the acute or chronic effects of leptin to reduce food intake (8) . These observations suggest that other neurons besides those expressing Pomc mediate most of the effects of leptin to suppress appetite. The specific neuronal populations involved in mediating the chronic anorexic effects of leptin on appetite and body weight regulation, however, have not been fully elucidated. In the present study, we found that Shp2 deletion in POMC neurons attenuated the chronic but not the acute effects of leptin on appetite. Previous studies showed that mice with disruption of Shp2 signaling in the entire CNS are obese and resistant to the anorexic effects of leptin (12) . Our data corroborate the results by Banno et al. (2) , who found that mice with Shp2 deletion in POMC neurons had a modest impairment of the anorexic responses to leptin, suggesting that Shp2 signaling in POMC neurons contributes, at least in part, to the chronic effects of leptin on appetite. Taken together, these observations suggest that Shp2 signaling in POMC neurons plays a modest role in long-term regulation of food intake by leptin.
Role of Shp2 Signaling in POMC Neurons in Mediating the Chronic BP Effects of Leptin
Our finding that inactivation of Shp2 signaling in POMC neurons increased BP, compared with control mice, was unexpected. However, the increase in BP was associated with increased adiposity, which could have activated other signaling pathways. The current studies suggest that increases in leptin associated with increased adiposity are unlikely to explain the elevated BP, since mice with Shp2 deficiency did not have a rise in BP during chronic leptin infusion. The mechanisms responsible for the effects of Shp2 deficiency in POMC neurons to raise BP are unclear and will require further studies to assess the potential role of increased adiposity and other signaling pathways.
In our previous studies, we found that intact LRs and STAT3 signaling on POMC neurons, as well as intact MC4R are crucial for leptin to raise BP (8, 10) , indicating that the brain POMC-MC4R system mediates the increases in renal sympathetic nerve activity and the hypertensive effects of leptin (8, 16) . Leptin elicits multiple postreceptor signaling events in POMC neurons that could mediate the increase in sympathetic activity and BP (13) . In addition, one important negative regulator of leptin signaling is protein tyrosine phosphatase 1B (PTP1B). Mice with total body PTP1B deletion are leaner, more responsive to the anorexic effects of leptin, and have higher BP compared with control mice (3, 4) . However, the role of PTP1B in POMC neurons in regulating BP and metabolic function is unclear. . Metabolic and motor activity responses to chronic leptin infusion (2 g·kg Ϫ1 ·min Ϫ1 ) in Shp2 flox/flox (n ϭ 9) and Shp2/Pomc-cre mice (n ϭ 7) mice. Plasma levels of glucose (A), insulin (B), and leptin (C) measured during control, day 7 of leptin infusion, and on the last day of recovery period. Whole body V O2 (D) and motor activity (E) during control, chronic leptin infusion, and recovery period. #P Ͻ 0.05 compared with baseline period.
The role of Shp2 signaling in mediating the chronic BP effects of leptin has, to our knowledge, not been previously reported. Our results indicate that Shp2 signaling in POMC neurons contributes, at least in part, to the chronic hypertensive effects of leptin. Our findings are also consistent with the observation that the BP effects of leptin are gradual, requiring several days for significant increases in BP to occur (8, 10, 16) . It is possible that the transcriptional activity of Shp2 to increase production of ␣-MSH, a key POMC neurotransmitter that activates MC4R in downstream target neurons, plays a role in the long-term effects of leptin on sympathetic activity and BP regulation. However, further studies are needed to test this hypothesis.
The effects of leptin on HR were transient in control and Shp2/Pomc-cre mice. In addition, we found that Shp2 signaling in POMC neurons did not significantly alter the BP response to acute stress. Since we previously demonstrated an important role for LR in POMC neurons for normal BP response to acute stress, these observations suggest that other signaling pathways activated by leptin in POMC neurons are involved in mediating leptin's effect to modulate autonomic responses to acute stress.
Previous studies have shown that leptin replacement therapy into the lateral ventricle increases motor activity in leptindeficient mice (11) , even compared with pair-fed mice, suggesting that central neural mechanisms are involved in the changes in motor activity rather than reduction in food intake and weight loss (15) . In our present study, chronic leptin infusion significantly reduced motor activity by about the same amount in control mice and mice with deletion of Shp2 signaling in POMC neurons. There are at least two explanations for this finding. First, this could suggest that Shp2 signaling in POMC neurons does not play a major role in mediating the effects of leptin to reduce motor activity. However, reduced motor activity caused by leptin in control mice and mice with Shp2 deletion in POMC neurons could be due to reduction in activity associated with decreased appetite and, therefore, reduced activity for seeking food. It is also possible that the impact of leptin on motor activity may differ according to the model studied and level of obesity (8, 11, 15) .
Although our results suggest that Shp2 signaling in POMC neurons is important in mediating the chronic hypertensive effects of leptin, leptin may also influence BP regulation via other signaling pathways, such as Irs2 signaling. In addition, POMC neurons are located in the forebrain and hindbrain of the nucleus tractus solitarius, and the specific role of Shp2 signaling in POMC neurons in these different areas of the CNS in mediating the effects of leptin on food intake and blood pressure is still unknown. Further studies are needed to unravel the complex actions of leptin on sympathetic activity and BP regulation.
In summary, we demonstrated that leptin's chronic BP and antidiabetic effects are mediated, at least in part, by activation of Shp2 signaling in POMC neurons. In addition, deficiency of Shp2 signaling in POMC neurons modestly increased body weight and fat mass, while slightly attenuating the chronic anorexic effects of leptin. These findings provide new insights into potential signaling pathways by which leptin may exert its divergent control of appetite, BP, and glucose homeostasis.
Perspectives and Significance
Previous studies indicate that leptin may contribute to activation of the sympathetic nervous system and hypertension in obese subjects mainly by stimulation of POMC neurons. Our results indicate that intact Shp2 signaling in POMC neurons is important for leptin's chronic BP effects. However, Shp2 signaling on POMC neurons apparently plays only a modest role in normal body weight regulation and in mediating leptin's effects on appetite. Therefore, the anorexic effects of leptin appear to be mediated, at least in part, either by Shp2 signaling in other neuronal populations or by another signaling pathway. Although forebrain deficiency of Shp2 causes obesity and many characteristics of metabolic syndrome, the specific neuronal populations involved are still unclear and deserve further investigation. Shp2 signaling in POMC neurons may help explain the differential metabolic and cardiovascular effects of leptin.
